FR2511866B1 - Formulations pharmaceutiques de pro-insuline humaine - Google Patents

Formulations pharmaceutiques de pro-insuline humaine

Info

Publication number
FR2511866B1
FR2511866B1 FR8214597A FR8214597A FR2511866B1 FR 2511866 B1 FR2511866 B1 FR 2511866B1 FR 8214597 A FR8214597 A FR 8214597A FR 8214597 A FR8214597 A FR 8214597A FR 2511866 B1 FR2511866 B1 FR 2511866B1
Authority
FR
France
Prior art keywords
pharmaceutical formulations
human proinsulin
proinsulin
human
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8214597A
Other languages
English (en)
French (fr)
Other versions
FR2511866A1 (fr
Inventor
Ronald Eugene Chance
Bruce Hill Frank
John Allison Galloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2511866A1 publication Critical patent/FR2511866A1/fr
Application granted granted Critical
Publication of FR2511866B1 publication Critical patent/FR2511866B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR8214597A 1981-08-27 1982-08-25 Formulations pharmaceutiques de pro-insuline humaine Expired FR2511866B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29675281A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
FR2511866A1 FR2511866A1 (fr) 1983-03-04
FR2511866B1 true FR2511866B1 (fr) 1986-08-14

Family

ID=23143402

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8214597A Expired FR2511866B1 (fr) 1981-08-27 1982-08-25 Formulations pharmaceutiques de pro-insuline humaine

Country Status (21)

Country Link
JP (1) JPS5846023A ( )
AU (1) AU552054B2 ( )
BE (1) BE894186A ( )
CA (1) CA1176160A ( )
CH (1) CH650677A5 ( )
DE (1) DE3232036A1 ( )
FR (1) FR2511866B1 ( )
GB (1) GB2104380B ( )
HU (1) HU193522B ( )
IE (1) IE53829B1 ( )
IL (1) IL66610A ( )
IT (1) IT1153184B ( )
LU (1) LU84358A1 ( )
MW (1) MW3782A1 ( )
MY (1) MY8700757A ( )
NL (1) NL8203316A ( )
NZ (1) NZ201683A ( )
PH (1) PH18716A ( )
SE (1) SE8204871L ( )
ZA (1) ZA826157B ( )
ZW (1) ZW17382A1 ( )

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
EP0166971B1 (de) * 1984-06-09 1990-02-28 Hoechst Aktiengesellschaft Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
ES2331342B1 (es) * 2006-05-22 2010-10-13 Consejo Superior Investg.Cientificas Uso de la proinsulina para la elaboracion de una composicion farmaceutica neuroprotectora, composicion terapeutica que la contiene y sus aplicaciones.
USD1010056S1 (en) * 2020-08-25 2024-01-02 Magpul Industries Corp. Gun sight

Also Published As

Publication number Publication date
HU193522B (en) 1987-10-28
LU84358A1 (fr) 1983-02-28
ZW17382A1 (en) 1982-11-17
IL66610A0 (en) 1982-12-31
IE53829B1 (en) 1989-03-15
FR2511866A1 (fr) 1983-03-04
GB2104380B (en) 1984-12-05
PH18716A ( ) 1985-09-11
ZA826157B (en) 1984-04-25
NL8203316A (nl) 1983-03-16
IL66610A (en) 1985-11-29
AU8759582A (en) 1983-03-03
BE894186A (fr) 1983-02-24
IT1153184B (it) 1987-01-14
IT8223019A0 (it) 1982-08-27
MW3782A1 (en) 1984-06-13
JPS5846023A (ja) 1983-03-17
IE822062L (en) 1983-02-27
SE8204871D0 (sv) 1982-08-25
MY8700757A (en) 1987-12-31
CA1176160A (en) 1984-10-16
NZ201683A (en) 1985-08-16
CH650677A5 (de) 1985-08-15
AU552054B2 (en) 1986-05-22
SE8204871L (sv) 1983-02-28
DE3232036A1 (de) 1983-03-10
GB2104380A (en) 1983-03-09

Similar Documents

Publication Publication Date Title
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
AU551719B2 (en) Anthralin compositions for treatment of skin diseases
IT7921111A0 (it) Dispositivo per la respirazione artificiale di pazienti.
IT8248677A0 (it) Formulazioni farmaceutiche
BE894188A (fr) Formulations pharmaceutiques comprenant de l'insuline et de la pro-insuline humaine
FR2513126B1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain
NZ191102A (en) Pharmaceutical formulations of galactomannan
FI824098A0 (fi) Terapeutiskt medel
AR228396A1 (es) Metodo para la preparacion de composiciones farmaceuticas para el tratamiento de la piel
MC1878A1 (fr) Compositions pharmaceutiques
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
FR2511866B1 (fr) Formulations pharmaceutiques de pro-insuline humaine
PT84933A (fr) Procede de preparation de cyclodepsipeptides et compositions pharmaceutiques qui les contiennent
IT7850483A0 (it) Combinazione di farmaci avente azione antitrombotica e procedimento per la sua preparazione
IT1170861B (it) Ester di mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
FR2618676B1 (fr) Compositions pharmaceutiques antivirales
IT8520712A0 (it) Formulazioni farmaceutiche per stimolare la liberazione di ormone somatotropo.
IT8267343A0 (it) Composizioni farmaceutiche contenenti l argento sulfadiazina come sostanza attiva e procedimento per laloro preparazione
PT67907A (fr) Procede pour la preparation de 2'-hydroxy-2 d'addition d'acides et compositions pharmaceutiques qui les contiennent.
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
DOP1981004094A (es) Composicion farmaceutica de liberacion prolongada
NO830819L (no) Farmasoeytiske preparater for behandling av huden.
FI840636A0 (fi) Foerfarande foer framstaellning av en fysiologiskt soenderfallande ester av antibakterisk 2 -klormetyl-2 -metylpenam-3 -karboxylsyrasulfon
BR6501388U (pt) Conjunto didatico para prevencao de doencas dentarias
MX9203614A (es) Formulacion farmaceutica de liberacion controlada para administracion oral.

Legal Events

Date Code Title Description
ST Notification of lapse